IPO registrations (S-1, F-1) · Registrants
OMEROS CORP
- SEC CIK
- 1285819 · filings on EDGAR ↗
- Registration
- Form S-1, first filed 2008-01-09, last 2010-08-10; 2 initial registrations, 6 amendments
- Outcome
- Final prospectus filed 2009-10-08; declared effective 2009-10-07; withdrawal requested 2011-05-10
- Industry (SIC)
- Pharmaceutical Preparations 2834
- Incorporated in
- WA
- Business address
- 201 ELLIOTT AVENUE WEST, Seattle, WA 98119
- EIN
- 91-1663741
- Ticker
- OMER (Nasdaq)
- EDGAR entity type
- operating
- Insiders and CEO pay
- OMEROS CORP on the corporate pages
Offering terms
- Proposed price range
- $10.00–$12.00 per share (S-1/A filed 2009-10-02)
- Final price
- $10.00 per share, within the range (424B4 filed 2009-10-08, an initial public offering)
- Shares sold
- 6,820,000
- Gross proceeds
- $68,200,000 before underwriting discounts and any over-allotment option
- Listing
- Nasdaq under the symbol OMER
- Lead underwriters
- Deutsche Bank (3,478,200 shares)
- Syndicate
- Wedbush Securities (1,261,700); Canaccord Genuity (1,091,200); Needham & Company (716,100); National Securities Corporation (136,400)
Read from the cover pages of the filings listed under “Prospectus pages read” below; check the document for anything that matters.
On this site
- Business registration: OMEROS CORPORATION EXACT (EIN (EXACT, as the state registration reports it))
- Business registration: Omeros Corporation Fuzzy (name and state)
- Business registration: Omeros Corporation Fuzzy (name and state)
- Business registration: Omeros Corporation Fuzzy (name and state)
- Business registration: Omeros Corporation Fuzzy (name and state)
- Business registration: OMEROS CORPORATION Fuzzy (name and state)
- Business registration: OMEROS CORPORATION Fuzzy (name and state)
- Business registration: OMEROS CORPORATION Fuzzy (name and state)
- Form 5500 plan sponsor: OMEROS CORPORATION EXACT (EIN (EXACT))
- Federal award recipient: OMEROS CORPORATION Fuzzy (name and state)
- Lobbying client: OMEROS CORPORATION Fuzzy (name and state)
- Lobbying client: OMEROS CORPORATION Fuzzy (name and state)
- Lobbying client: OMEROS CORPORATION Fuzzy (name and state)
- Lobbying client: OMEROS CORPORATION Fuzzy (name and state)
- Lobbying client: OMEROS CORPORATION Fuzzy (name and state)
- Lobbying client: OMEROS CORPORATION Fuzzy (name and state)
- Lobbying client: OMEROS CORPORATION Fuzzy (name and state)
- Lobbying client: OMEROS CORPORATION Fuzzy (name and state)
- Lobbying client: OMEROS CORPORATION Fuzzy (name and state)
- Lobbying client: OMEROS CORPORATION Fuzzy (name and state)
- SEC filer: OMEROS CORP EXACT (CIK (EXACT))
- Person page: Arnold C Hanish Fuzzy (officer, director or 10% owner on the company's Forms 3, 4 and 5 (Director))
- Person page: Thomas J Cable Fuzzy (officer, director or 10% owner on the company's Forms 3, 4 and 5 (Director))
Filings 13
| Filed | Form | What it is | Name as filed | EDGAR |
|---|---|---|---|---|
| 2008-01-09 | S-1 | S-1 (registration) | OMEROS CORP | 0000891020-08-000011 ↗ |
| 2008-04-01 | S-1/A | S-1/A (amendment) | OMEROS CORP | 0000891020-08-000079 ↗ |
| 2008-05-08 | S-1/A | S-1/A (amendment) | OMEROS CORP | 0000891020-08-000113 ↗ |
| 2009-05-15 | S-1/A | S-1/A (amendment) | OMEROS CORP | 0000950134-09-010871 ↗ |
| 2009-06-23 | S-1/A | S-1/A (amendment) | OMEROS CORP | 0000950123-09-016265 ↗ |
| 2009-09-16 | S-1/A | S-1/A (amendment) | OMEROS CORP | 0000950123-09-043626 ↗ |
| 2009-10-02 | S-1/A | S-1/A (amendment) | OMEROS CORP | 0000950123-09-047963 ↗ |
| 2009-10-07 | EFFECT | EFFECT (declared effective) | OMEROS CORP | 9999999995-09-002786 ↗ |
| 2009-10-08 | 424B4 | 424B4 (final prospectus) | OMEROS CORP | 0000950123-09-049121 ↗ |
| 2010-08-10 | S-1 | S-1 (registration) | OMEROS CORP | 0000950123-10-075694 ↗ |
| 2010-08-27 | EFFECT | EFFECT (declared effective) | OMEROS CORP | 9999999995-10-002578 ↗ |
| 2010-10-18 | EFFECT | EFFECT (declared effective) | OMEROS CORP | 9999999995-10-002973 ↗ |
| 2011-05-10 | RW | RW (withdrawal request) | OMEROS CORP | 0001193125-11-134363 ↗ |
Prospectus pages read 2
| Filed | Form | Read as | Range | Price | Shares | Proceeds | Listing | Underwriters | What was found | Document |
|---|---|---|---|---|---|---|---|---|---|---|
| 2009-10-02 | S-1/A | registration statement | $10.00–$12.00 | 6,820,000 | - | Nasdaq OMER | 0 | primary document; range, price line, shares headline, proceeds computed, price outside the range dropped | document ↗ | |
| 2009-10-08 | 424B4 | final prospectus | $10.00 | 6,820,000 | $68,200,000 | Nasdaq OMER | 5 | primary document; price sentence, shares headline, proceeds table, underwriting table 5 | document ↗ |
Officers, directors and large holders Forms 3, 4 and 5
| Insider | Role | Title | Filings | Years | On this site |
|---|---|---|---|---|---|
| Aspiri Ray | Director | 18 | 2009–2022 | ||
| Cable Thomas J. | Director | 45 | 2009–2026 | person page Fuzzy | |
| Demopulos Gregory A MD | Director,Officer; Director,Officer,TenPercentOwner; Officer | Chairman, CEO & President; CHAIRMAN, CEO & PRESIDENT; CHIARMAN, CEO & PRESIDENT; See General Remarks | 36 | 2009–2026 | |
| Demopulos Peter A MD | Director | 30 | 2009–2026 | ||
| Hood Leroy E. MD PhD | Director | 25 | 2009–2026 | ||
| Kelbon Marcia S. | Officer | VP Patent and General Counsel; VP, Patent & Gen Cnsl, Sec. | 36 | 2009–2019 | |
| Tripet Jean-Philippe | Director | 5 | 2009–2011 | ||
| SPIEGELMAN DANIEL K | Director | 4 | 2009–2012 | ||
| HANISH ARNOLD C | Director | 21 | 2012–2026 | person page Fuzzy | |
| JACOBSEN MICHAEL A | Officer | VP Finance and CAO; VP FINANCE AND CAO; VP, Finance and CAO, Treasurer; VP, Finance & CAO | 19 | 2013–2024 | |
| Shah Rajiv | Director | 14 | 2015–2026 | ||
| Bumol Thomas F. | Director | 11 | 2019–2026 | ||
| Cancelmo Peter B | Officer | See Remarks; VP, GEN. COUNSEL & CORP. SEC.; VP, General Counsel; VP, GENERAL COUNSEL | 11 | 2019–2026 | |
| Zumwalt Kurt | Director | 5 | 2020–2022 | ||
| Perkinson Diana T. | Director | 5 | 2023–2026 | ||
| Borges David J. | Officer | VP, Finance & CAO | 7 | 2024–2026 | |
| Schocken Joseph L | Director | 2 | 2026 |
Everyone who filed an insider report for this company, from the SEC’s Insider Transactions Data Sets (2006 on). Person pages are matched by name and state only.
Data: SEC EDGAR. The quarterly full index (every S-1, S-1/A, F-1 and F-1/A since 1993, with the pricing prospectus, notice of effectiveness and withdrawal request of each registrant) and the company submissions data (SIC, state of incorporation, address, EIN, tickers, former names). Company details are what EDGAR holds today, not at the time of the filing.
Also on this site Fuzzy
| Record | Name as filed | Where | Dataset | Matched by |
|---|---|---|---|---|
| Business registration | OMEROS CORPORATION | WA | State business registries | EIN (EXACT, as the state registration reports it) |
| Plan sponsor | OMEROS CORPORATION | WA | Form 5500 (employee benefit plans) | EIN (EXACT) |
| SEC filer | OMEROS CORP | SEC filers (EDGAR) | CIK (EXACT) | |
| Business registration | Omeros Corporation | State business registries | name and state | |
| Business registration | Omeros Corporation | State business registries | name and state | |
| Business registration | Omeros Corporation | State business registries | name and state | |
| Business registration | Omeros Corporation | State business registries | name and state | |
| Business registration | OMEROS CORPORATION | State business registries | name and state | |
| Business registration | OMEROS CORPORATION | State business registries | name and state | |
| Business registration | OMEROS CORPORATION | State business registries | name and state | |
| Form 5500 plan sponsor | OMEROS CORPORATION | EIN (EXACT) | ||
| Federal award recipient | OMEROS CORPORATION | Federal spending (USAspending) | name and state | |
| Lobbying client | OMEROS CORPORATION | Federal lobbying (LDA) | name and state | |
| Lobbying client | OMEROS CORPORATION | Federal lobbying (LDA) | name and state | |
| Lobbying client | OMEROS CORPORATION | Federal lobbying (LDA) | name and state | |
| Lobbying client | OMEROS CORPORATION | Federal lobbying (LDA) | name and state | |
| Lobbying client | OMEROS CORPORATION | Federal lobbying (LDA) | name and state | |
| Lobbying client | OMEROS CORPORATION | Federal lobbying (LDA) | name and state | |
| Lobbying client | OMEROS CORPORATION | Federal lobbying (LDA) | name and state | |
| Lobbying client | OMEROS CORPORATION | Federal lobbying (LDA) | name and state | |
| Lobbying client | OMEROS CORPORATION | Federal lobbying (LDA) | name and state | |
| Lobbying client | OMEROS CORPORATION | Federal lobbying (LDA) | name and state | |
| Person page | Arnold C Hanish | People (Form 990 officers, directors and employees) | officer, director or 10% owner on the company's Forms 3, 4 and 5 (Director) | |
| Person page | Thomas J Cable | People (Form 990 officers, directors and employees) | officer, director or 10% owner on the company's Forms 3, 4 and 5 (Director) |
Matched by an identifier (EIN, CIK, CRD), by name and state or city, or by street address; a shared name or address is not proof of the same person or organization. Every link says how it was made; how the cross-referencing works.
Others with the same interests
SIC industry Pharmaceutical Preparations, WA first:
- PATHOGENESIS CORP WA
- DENDREON CORP WA
- CORUS PHARMA INC WA
- CytoDyn Inc. WA
- Trubion Pharmaceuticals, Inc WA
- Light Sciences Oncology Inc WA
- Cocrystal Pharma, Inc. WA
- ALDER BIOPHARMACEUTICALS INC WA
- PHASERX, INC. WA
- CHINOOK THERAPEUTICS, INC. WA
In other datasets, the same topic (Health) in WA:
- Nonprofit: ACUPUNCTURE RELIEF PROJECT (Nonprofits (IRS Form 990))
Interests: Pharmaceutical Preparations · Health